Provided by Tiger Trade Technology Pte. Ltd.

MapLight Therapeutics, Inc.

11.36
+0.15001.34%
Volume:563.46K
Turnover:6.31M
Market Cap:526.85M
PE:-2.25
High:11.44
Open:11.21
Low:10.51
Close:11.21
52wk High:40.43
52wk Low:9.10
Shares:46.38M
Float Shares:13.40M
Volume Ratio:0.92
T/O Rate:4.20%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-5.0580
EPS(LYR):-18.5643
ROE:-111.55%
ROA:-67.11%
PB:1.51
PE(LYR):-0.61

Loading ...

Aug 21, 2026

Beneficial Ownership Change

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Aug 14, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 13, 2026

Major Issues Report

Form 8-K - Current report
Aug 03, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 30, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 27, 2026

Major Issues Report

Form 8-K - Current report
Jul 17, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 17, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 15, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 15, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 15, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 15, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 15, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 15, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 15, 2026

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 24, 2026

Major Issues Report

Form 8-K - Current report
Jun 22, 2026

Major Issues Report

Form 8-K - Current report
Jun 19, 2026

Major Issues Report

Form 8-K - Current report
May 15, 2026

Beneficial Ownership Change

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
May 15, 2026

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]